Date

2022-10

Author

Tunçbağ , Nurcan
Ayar , Enes Sefa

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

112
views

38
downloads

Cite This

Molecular heterogeneity and resistance to the treatment are among the obstacles in developing treatment strategies in cancer. Therefore, transforming patient-specific molecular data into clinically interpretable knowledge is fundamental in personalized medicine. However, not all molecular alterations drive cancer. The distinction of drivers from latent drivers and passengers, their cooperativity and exclusivity, and the temporal order of accumulation of molecular alterations is a crucial yet daunting, unsolved task. Early alterations in temporal order can inform about network rewiring and direct the identification of drug targets. The challenge in temporal modelling of cancer and the respective elucidation of the chronological order of molecular alterations, especially in terms of the evolution of networks beyond the alterations, remains elusive. The focus of this study is directly devoted to address this challenge. We developed an integrative computational modeling approach to reveal the network-based history of tumor progression and to design personalized therapeutic strategies based on the validated models. The core method in this approach is the graph-based cellular automata (GCA), which is a discrete dynamic model. GCA model can simulate complex systems by considering local interaction rules, and it gives insights into the underlying mechanism of complex behavior. The reference graph is a tissue-specific interactome consisting of protein-protein interactions and regulatory interactions. Proteins are assumed to have a state of being for cancer-driving or neutral/against cancer progression. We applied this model to the cell line-dependent data in DepMap which consists of both molecular alterations (mutation transcriptomic and proteomic data) and drug response. As a result of a rigorous dynamic network comparison we constructed a network-based taxonomy of the tumors both within each cancer type and cross-cancer-types. We expect that this approach from molecular alterations to dynamic networks will transform the already available large datasets to gain new clinically relevant insights and improve personalized medicine.

URI

https://hibit2022.ims.metu.edu.tr/
https://hdl.handle.net/11511/101926

Collections

Graduate School of Informatics, Conference / Seminar